Financials
- Market Capitalization 8.33 B
- Employee 131
- Founded 2006
- CEO N/A
- Website www.protagonist-inc.com
- Headquarter Delaware, United States
- FIGI BBG002B63KM7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-42.6
Relación precio/flujo de caja
120.66
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1008 | TGTX TG Therapeutics, Inc. - Common Stock | 55.15 USD | +0.25% | -4.44% | +12.55% | +41.45% | 8.44 B USD | ||
| 1010 | SYRE Spyre Therapeutics, Inc. - Common Stock | 104.42 USD | +11.41% | +12.57% | +28.01% | +336.72% | 9.07 B USD | ||
| 1020 | APGE Apogee Therapeutics, Inc. - Common Stock | 134.02 USD | +0.15% | +0.41% | +49.48% | +150.08% | 8.30 B USD | ||
| 1021 | IBRX ImmunityBio, Inc. - Common Stock | 7.93 USD | +1.80% | -7.25% | +9.38% | +171.58% | 8.31 B USD |